Katia O Manova-Todorova

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0003-0915-6696

发表论文 167 篇 · 总被引 13788 次 · h-index 40

代表论文

• Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies (2024 · Proceedings of the National Academy of Sciences · 被引 62)
• Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 40)
• FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer (2024 · EMBO Molecular Medicine · 被引 9)
• Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration (2025 · Cancer Research · 被引 7)
• Single Cell Analysis of Treatment–Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)
• Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate (2026 · Journal of Clinical Investigation)